中文 | English
Return
Total: 1317 , 1/132
Show Home Prev Next End page: GO
Author:(WANG Xiaodong)

1.Study on Compatible Stability of Cefepime Dihydrochloride Mixed with Total Parenteral Nutrient

Xiaodong WANG

China Pharmacy 2007;0(26):-

2.The correlation of serum adiponectin,C-reactive protein levels and carotid atherosclerosis plaque in patients with acute cerebral infarction

Xiaodong WANG

Chinese Journal of Postgraduates of Medicine 2013;36(25):17-20

3.Clinical features of gout complicate d with increased carbohydrate antigen 724

Xiaodong WANG

Chinese Journal of Rheumatology 2017;21(4):262-264

4.Research progress of H19 gene in the field of tumor research

Xiaodong WANG

Fudan University Journal of Medical Sciences 2017;44(2):224-230

5.Biocompatibility of different coronary stents and restenosis following implantation

Xiaodong WANG

Chinese Journal of Tissue Engineering Research 2007;0(09):-

6.Skin toxicities of epidermal growth factor receptor inhibitors

Lu WANG ; Xiaodong XIE

Journal of International Oncology 2012;39(10):784-787

7.How to standardize and optimize the clinical practice pattern to improve diagnosis and treatment of age-related macular degeneration: interpretation of the Age-Related Macular Degeneration Guidelines of Royal College of Ophthalmologists

Fenghua WANG ; Xiaodong SUN

Chinese Journal of Ocular Fundus Diseases 2012;28(5):436-440

8.AO titanium elastic nail combined with autologous hone marrow injection for treatment of simple bone cysts of the long bones in children

Jianfeng FANG ; Xiaodong WANG

Chinese Journal of Orthopaedics 2009;29(7):653-657

9.The role of epigenetics on anti-angiogenesis therapy

Mei WANG ; Xiaodong JIANG

Journal of International Oncology 2017;44(5):380-382

10.Protective Effects of Sophoramine on Acute Myocardial Infarction and Reperfusion Injury in Conscious Rats

Ying JIN ; Xiaodong WANG

Chinese Traditional and Herbal Drugs 1994;0(07):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1317 , 1/132 Show Home Prev Next End page: GO